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a b s t r a c t
Primary ovarian insufﬁciency (POI) affects 1% of women under the age of 40 and is associated with
premature ovarian follicle depletion. TAF4b deﬁciency in adult female mouse models results in
hallmarks of POI including stereotyped gonadotropin alterations indicative of early menopause, poor
oocyte quality, and infertility. However, the precise developmental mechanisms underlying these adult
deﬁcits remain unknown. Here we show that TAF4b is required for the initial establishment of the
primordial follicle reserve at birth. Ovaries derived from TAF4b-deﬁcient mice at birth exhibit delayed
germ cell cyst breakdown and a signiﬁcant increase in Activated Caspase 3 staining compared to control
ovaries. Culturing neonatal TAF4b-deﬁcient ovaries with the pan-caspase inhibitor ZVAD-FMK sup-
presses the excessive loss of these oocytes around the time of birth. These data reveal a novel TAF4b
function in orchestrating the correct timing of germ cell cyst breakdown and establishment of the
primordial follicle reserve during a critical window of development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
At birth, the mammalian ovary contains a ﬁnite number of
oocytes, most of which will die during the process of follicle
development. In contrast, a small number of high quality oocytes
are destined for ovulation during adulthood (Jones and Pepling,
2013). Proper regulation of the initial primordial follicle pool is
critical for the ovary to maintain sufﬁcient numbers of oocytes for
long-term ovulation and fertility. Disruption of the normal balance
between oocyte survival and death usually leads to a reduction of
the ovarian reserve and impaired fertility (reviewed in McLaughlin
and McIver (2009)). While many effectors of oocyte death in the
ovary are known, the upstream transcriptional regulators that
ensure for proper primordial follicle number and survival at birth,
and their associated mechanisms, remain largely unknown.
Towards this goal, we are studying the role the transcriptional
co-activator TAF4b during oogenesis and folliculogenesis using a
TAF4b-deﬁcient mouse model (Freiman et al., 2001).
TAF4b is a gonadal-enriched subunit of the TFIID complex that
is critical for female fertility in the mouse. TFIID is a multi-protein
general transcription factor composed of the TATA-box binding
protein (TBP) and 14 TBP-associated factors (TAFs) (Freiman et al.,
2001). TAF4b-deﬁcient female mice are infertile and suffer from
hallmarks of premature ovarian aging including persistent estrous,
elevated serum follicle stimulating hormone (FSH) and reduced
primordial follicle numbers (Voronina et al., 2007; Lovasco et al.,
2010). In addition, the human gene encoding TAF4b has been
linked to primary ovarian insufﬁciency (POI) in women (Knauff
et al., 2009) as well as human oocyte quality (Di Pietro et al.,
2008). Thus, the study of TAF4b in the mouse is highly relevant to
the potential role of TAF4b in the proper regulation of human
ovarian follicle assembly and survival.
The ﬁdelity of each step of mammalian oogenesis and follicu-
logenesis is essential for proper oocyte development, ovulation
and the developmental potential of the future embryo. The
embryonic timeline of murine primordial follicle assembly is
well-documented, beginning with germ cell clusters formed
through incomplete cytokinesis during mid-embryogenesis. These
clusters constitute “cysts” of oogonia, many of which remain
associated by intercellular bridges (Pepling and Spradling, 1998;
Pepling, 2006; Pepling, 2012a,b) or cyst aggregation (Mork et al.,
2012). At embryonic day (E) 13.5, mitosis ceases, and oogonia
enter into meiosis I, becoming “oocytes” which usually arrest in
the diplotene stage of Prophase I around the time of birth.
Concurrently, cysts of germ cells begin undergoing “breakdown”,
in which most of the oocytes are lost through programmed cell
death (reviewed in Pepling (2012a,b)). In contrast, the remaining
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oocytes become surrounded by a single layer of somatic pre-
granulosa cells, forming “primordial follicles”. While seemingly
simple, this process of primordial follicle assembly requires the
intricate orchestration of somatic cell invasion into oogonial cysts,
tightly controlled changes in hormone levels, and a unique
Caspase 2-dependent apoptotic cascade (Bergeron et al., 1998;
Morita et al., 2001; Takai et al., 2007; Lobascio et al., 2007; Tingen
et al., 2009). Cyst breakdown is hypothesized to result from
inherent ovarian quality control mechanisms, pre-clearing defec-
tive germ cells from the future ovarian reserve. In addition, germ
cells that do not receive adequate somatic investment for survival
are removed by apoptosis (Tingen et al., 2009). However, the
molecular and cellular mechanisms required for proper primordial
follicle assembly and survival remain largely unknown.
One known regulator of female germ cell cyst breakdown and
proper primordial follicle assembly is estrogen (Lei et al., 2010).
Estrogen is a steroid hormone that plays important roles in normal
ovarian development by promoting granulosa proliferation and
differentiation. 17β-estradiol (β-estradiol) is the most bioactive form
of endogenous estrogen and is produced by granulosa cells of the
ovary. By regulating follicle growth and maturation, β-estradiol
modulates the action of FSH and facilitates further β-estradiol
production (Drummond and Fuller, 2012). Furthermore, β-estradiol
has been shown to promote germ cell survival during the late
embryonic and early neonatal period, suggesting that separation
from maternal estrogen around the time of birth may facilitate cyst
breakdown and associated apoptosis (Chen et al., 2009; Karavan and
Pepling, 2012). In addition, aberrant activation of estrogen signaling
by genistein (Jefferson et al., 2006; Chen et al., 2007) or diethyl-
stilbestrol (Muñoz-de-Toro et al., 2011; Karavan and Pepling, 2012)
perturbs normal cyst breakdown, leading to multiple oocyte follicles.
Moreover, estrogen receptors have been shown to be expressed in
the somatic cells of the rodent ovary (Fitzpatrick et al., 1999; Juengel
et al., 2006), and disruption of these receptors leads to dramatic
reproductive phenotypes (Lubahn et al., 1993; Korach et al., 1996).
While the precise role for estrogen in promoting cyst breakdown,
primordial follicle assembly, and long-term fertility is unknown, it is
clearly an essential regulator of this developmental transition.
In order to elucidate fundamental mechanisms associated with
healthy primordial follicle assembly, we have examined ovarian
development in the context of TAF4b-deﬁcient ovaries during the
late embryonic to early postnatal period. While TAF4b-deﬁcient
ovaries appear normal during late embryogenesis, they suffer
accelerated germ cell death by postnatal day (PND) 1. Excessive
germ cell loss in the TAF4b-deﬁcient ovaries is associated with
delayed onset of germ cell cyst breakdown compared to control
ovaries. Surprisingly, excessive germ cell loss in the TAF4b-
deﬁcient ovaries is associated with a signiﬁcant increase in
Activated Caspase 3, activation not normally observed during
normal cyst breakdown which is primarily dependent upon
Activated Caspase 2 (Bergeron et al., 1998; Morita et al., 2001;
Takai et al., 2007; Lobascio et al., 2007; Tingen et al., 2009).
Moreover, this form of germ cell attrition in the TAF4b-deﬁcient
ovaries can be prevented by apoptosis inhibition and β-estradiol
treatment. Together, these studies highlight the critical role of
TAF4b in the establishment of the initial and long-term postnatal
primordial follicle pool.
Results
TAF4b is required for postnatal oocyte survival immediately after
birth
As TAF4b-deﬁcient mice exhibit reduced primordial follicle num-
bers at PND 21 (Voronina et al., 2007), we aimed to determine the
precise timing of their demise. Immuno-staining for germ cell markers
Mouse Vasa Homolog (MVH) and Tra98 (Tanaka et al., 1997) within
the TAF4b-deﬁcient ovary was performed from late embryogenesis
through early postnatal development, and then compared to control
ovaries. Ovarian tissue sections obtained from TAF4b-deﬁcient (/)
or matched heterozygous (þ/) and wildtype (þ/þ) littermates
were stained with antibodies against germ cell markers MVH and
Tra98 (Fig. 1A). Heterozygous TAF4b mice are completely fertile and
were used as control littermates along with their wild-type counter-
parts. During late embryogenesis at E18.5, ovaries from all genotypes
are largely indistinguishable by germ cell density. In contrast, by PND
1, TAF4b (/) mice exhibit excessive and signiﬁcant Tra98-positive
germ cell depletion (Fig. 1B, po0.01, two-tailed T-test). When these
Fig. 1. Perinatal oocyte depletion in TAF4b (/) ovaries. (A) MVH (red) and Tra98
(green) staining were used as cytoplasmic and nuclear germ cell markers,
respectively, in 8 mm ovary tissue sections. DAPI (blue) denotes nuclei. TAF4b
(þ/) and ( /) ovaries exhibit comparable germ cell densities at E 18.5 (top),
while TAF4b (/) ovaries suffer excessive depletion of oocyte by PND 1 (bottom).
(B) Quantiﬁcation of stained tissue sections. Tra98-positive oocytes were counted
per section and total number was divided by total DAPI area. N¼4 for PND 0 TAF4b
(þ/) and (/). N¼5 for E18.5 TAF4b (/). N¼6 for E18.5 TAF4b (þ/), PND
1 TAF4b (þ/), and PND 1 TAF4b (/). **: two-tailed T-test, po0.01.
(C) Independent quantiﬁcation of stained tissue sections. MVH-positive oocytes
were counted per section and total number was divided by total DAPI area. N¼3 for
all groups. *: two-tailed T-test, po0.05.
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sections were quantiﬁed by MVH-positive cells, this germ cell deple-
tion was similarly observed (Fig. 1C, po0.05, two-tailed T-test). These
data are consistent when ovaries are stained via indirect immunohis-
tochemistry for germ cell marker Germ Cell Nuclear Antigen (GCNA,
Enders and May, 1994) or indirect immunoﬂuorescence of Tra98
(Supplementary Figs. 1–3), emphasizing the usefulness of Tra98 as a
marker of perinatal oocytes. Additionally, ovary sections stained
histologically with hematoxylin and eosin further support these
conclusions (Supplementary Figs. 4–6). Together, these data indicate
that the critical window of germ cell loss in these mice is at or around
the time of birth.
TAF4b promotes the correct timing of cyst breakdown and primordial
follicle development
Strikingly, germ cell densities determined at PND 0, or within a
few hours of birth, indicate that TAF4b-deﬁcient ovaries have
signiﬁcantly more oocytes than wild-type littermates (Fig. 1B and
C). As this is counterintuitive to their excessive demise just one
day later, cyst breakdown was examined more closely. At PND 0,
TAF4b (þ/þ) and (þ/) mice are undergoing normal cyst break-
down where small cysts becoming primordial follicles are
observed in these ovaries (Fig. 2, top panel; Supplementary
Figs. 2 and 5). In contrast, at PND 0 TAF4b (–/–) ovaries retain
large cysts of germ cells which have not initiated or completed
cyst breakdown commensurate with wild-type littermates (Fig. 2,
bottom panel; Supplementary Figs. 2 and 5). While large germ cell
cysts are observed in control mice at earlier time points (data not
shown), these data indicate that TAF4b is normally required to
initiate or facilitate proper cyst breakdown and complete primor-
dial follicle formation.
TAF4b-deﬁcient oocytes and somatic cells exhibit elevated levels of
Activated Caspase 3
Fetal germ cell death has been described through a variety of
mechanisms including apoptosis, autophagy, and shedding from
the ovarian cortex (Tingen et al., 2009). As TAF4b (/) germ cells
are largely absent by PND 1, we wanted to determine the cellular
mechanism responsible for their early demise. To this end, PND
0 ovaries were stained with an antibody against Activated Caspase
3 to determine the incidence of apoptosis. While PND 0 TAF4b
(þ/) ovaries exhibit little to no Activated Caspase 3 staining
(Fig. 3A, left panel), TAF4b (/) ovaries display many Activated
Caspase 3-positive oocytes and somatic cells, as well as pyknotic
nuclei (Fig. 3A, right panel). Indeed, quantiﬁcation of percent of
Activated Caspase 3 positive oocytes (cells in which both Tra98
and Activated Caspase 3 are apparent by immunoﬂuorescence,
divided by total Tra98 positive cells) is signiﬁcantly greater in
TAF4b (/) ovaries than in TAF4b (þ/þ) ovaries (Fig. 3B,
po0.001, two-tailed T-test). As this analysis only determined
percent of Activated Caspase 3-positive germ cells and excluded
other factors including pyknotic nuclei, the percentage of apopto-
tic germ cells in TAF4b (/) ovaries may be even larger.
Increased Activated Caspase 3 staining in TAF4b-deﬁcient ovaries
at PND 0 is consistent with a role for TAF4b in preventing oocyte
apoptosis.
ex vivo germ cell loss in TAF4b-deﬁcient ovaries is rescued by Caspase
inhibition
To more deﬁnitively test mechanisms of germ cell loss in the
context of the TAF4b (/) ovaries, ex vivo ovary culture was
employed as in Chen et al. (2007). We ﬁrst assessed the potential
Fig. 2. Delayed primordial follicle assembly in PND 0 TAF4b (/) ovaries. MVH (red) and Tra98 (green) staining were used as cytoplasmic and nuclear germ cell markers,
respectively, in 8 mm PND 0 ovary tissue sections. DAPI (blue) denotes nuclei. White dashed circles denote cysts. During the time in which TAF4b (þ/þ) mice are undergoing
normal cyst breakdown and primordial follicle assembly, TAF4b (/) oocytes persist in large cysts, indicating a deﬁcit in the process of cyst breakdown.
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Fig. 3. Increased incidence of Activated Caspase 3-positive oocytes and somatic cells in PND 0 TAF4b (/) ovaries. (A) Activated Caspase 3 (red) and Tra98 (green) staining
was performed in 8 mm PND 0 ovary tissue sections. TAF4b (/) ovaries (right panel) possess far greater numbers of Activated Caspase 3-positive oocytes relative to TAF4b
(þ/þ) ovaries (left panel). Inset: high magniﬁcation insets denote Activated Caspase 3-positive germ cells (red arrows), Activated Caspase 3-positive somatic cells (white
arrow), and pyknotic nuclei (yellow arrowheads) in TAF4b (/) ovaries, which are absent from TAF4b (þ/þ) ovaries. Green arrows denote non-apoptotic oocytes.
(B) Quantiﬁcation of apoptotic oocytes. Cells positive for both Activated Caspase 3 and Tra98 were counted per section and divided by the total number of Tra98-positive cells
per section. ***: N¼3, two-tailed T-test, po0.001.
K.J. Grive et al. / Developmental Biology 392 (2014) 42–51 45
functionality of our ex vivo ovary culture. TAF4b (þ/) and (/)
ovaries were harvested at E18.5 and cultured for three days until
“PND 1”. Ovaries were then sectioned and stained for Tra98-
positive germ cells (Fig. 4A). Indeed, the TAF4b / germ cell loss
observed immediately after birth in vivo (Fig. 4B) is recapitulated
in ex vivo ovary culture, allowing for the use of this method as a
complement to our in vivo work. To more directly test the
hypothesis that apoptosis is responsible for the germ cell death
observed around the time of birth in TAF4b (/) ovaries, the
pan-caspase inhibitor Z-VAD-FMK was utilized. Ovaries were
harvested at E18.5 from TAF4b (þ/þ) and (/) mice and
cultured for 4 days. One ovary from each mouse was cultured in
media containing 50mM Z-VAD-FMK, while the other ovary was
cultured in control media containing an appropriate amount of
DMSO vehicle. While TAF4b (/) ovaries cultured in control
media experience germ cell loss similar to that observed in vivo,
TAF4b (/) ovaries cultured in Z-VAD-FMK-containing media
experience a marked retention of Tra98-positive germ cells
(Fig. 5A). As expected, TAF4b (þ/þ) ovaries retain germ cells in
both control and treated culture conditions (Fig. 5B). Furthermore,
while there is some variability in culture results, both TAF4b
(þ/þ) and (/) ovaries exhibit a signiﬁcant increase in germ
cell density between control and Z-VAD-FMK-treated culture
conditions (po0.05, two-tailed T-test) when ovaries are cultured
in the presence of Z-VAD-FMK (Fig. 5C). This is to be expected of
TAF4b (þ/þ) ovaries as Z-VAD-FMK should inhibit normal cyst
breakdown as well as aberrant apoptosis, but this result is
particularly notable in TAF4b (/) ovaries. Additionally, there
is no signiﬁcant difference between Z-VAD-FMK treated TAF4b
(/) ovaries and control-treated TAF4b (þ/þ) ovaries,
suggesting that the pan-caspase treatment restores TAF4b-
deﬁcient germ cell densities to that which would be expected of
wild-type ovaries at the same time point. Furthermore, culture in
the presence of Z-VAD-FMK results in the loss of Activated Caspase
3 staining in cultured TAF4b (/) ovaries (Supplementary Fig. 7).
These data further implicate apoptosis as a primary mechanism of
germ cell loss in the context of the perinatal TAF4b-deﬁcient ovary.
Excessive germ cell loss in TAF4b-deﬁcient ovaries can be negated by
β-estradiol treatment
As β-estradiol has been shown to inhibit germ cell apoptosis
(Lei et al., 2010), ovary cultures in the presence of β-estradiol were
also performed. Ovaries from TAF4b (þ/þ) and (/) mice were
collected at E18.5 and cultured for 4 days. One ovary per mouse
was cultured in media containing 10 nM β-estradiol, while the
other ovary was cultured in control media containing an appro-
priate amount of ethanol vehicle. Ovaries were then sectioned and
stained with an antibody against Tra98. While TAF4b (/)
ovaries cultured in control media again experience the expected
germ cell loss similar to that observed in vivo, TAF4b (/)
ovaries cultured in the presence of β-estradiol experience a
retention of Tra98-positive germ cells (Supplementary Fig. 8A).
In contrast, TAF4b (þ/þ) ovaries experience retention of germ
cells regardless of culture conditions (Supplementary Fig. 8B).
However, TAF4b (þ/þ) ovaries exhibit no signiﬁcant difference
in germ cell density between control and β-estradiol-treated
culture conditions while TAF4b (/) ovaries exhibit signiﬁcant
retention of germ cells (po0.05, two-tailed T-test) when ovaries
are cultured in the presence of β-estradiol (Supplementary
Fig. 4. ex vivo-cultured PND 1 ovaries recapitulate in vivo oocyte depletion. (A) E18.5 TAF4b (þ/) and (/) ovaries were harvested and cultured until PND 1 in ovary
culture media. Ovaries were then embedded and stained for Tra98 (green) to assess germ cell numbers. Cultured TAF4b (/) experience oocyte depletion similar to in vivo
TAF4b (/) ovaries (right panel), while cultured TAF4b (þ/) ovaries maintain the oocyte reserve (left panel). (B) Representative sections of in vivo PND 2 TAF4b (þ/þ)
and (/) ovaries.
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Fig. 5. TAF4b (/) perinatal oocyte depletion is due primarily to apoptosis. E18.5 TAF4b (þ/þ) and (/) ovaries were harvested and cultured until PND 2 in control
media or media containing 50 mM Z-VAD-FMK. Ovaries were then embedded and stained for Tra98 (green) to assess germ cell numbers. (A) Oocyte depletion in TAF4b (/)
ovaries is inhibited in the presence of Z-VAD-FMK, but not control media. (B) In both culture conditions, TAF4b (þ/þ) ovaries maintain their oocyte reserve.
(C) Quantiﬁcation of oocyte reserve. Tra98-positive oocytes were counted per section and total number was divided by total DAPI area. N¼5 for Z-VAD-FMK-treated
TAF4b (þ/þ) and (/). N¼6 for control-treated TAF4b (þ/þ) and ( /). **: two-tailed T-test, po0.01.
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Fig. 8C). Similarly to Z-VAD-FMK treatment, there is no signiﬁcant
difference between β-estradiol-treated TAF4b (/) ovaries and
control-treated TAF4b (þ/þ) ovaries, suggesting that the
β-estradiol treatment restores TAF4b-deﬁcient germ cell densities
to that which would be expected of wild-type ovaries at the same
time point. Taken together, these data suggest that a critical aspect
of estrogen signaling may be perturbed in the early postnatal
TAF4b-deﬁcient ovary leading to aberrant cyst breakdown and
reduced oocyte survival.
Discussion
Regulating the precise level of oocyte survival at birth is critical
for establishing the proper primordial follicle reserve in the adult
ovary that is required for long-term fertility. Premature exhaustion
of this primordial follicle reserve is one feature of POI, which
affects 1% of womenworldwide (Knauff et al., 2009). While known
causes of this disorder include accelerated ovarian follicle deple-
tion, the molecular mechanisms and etiology underlying the
development of this disorder are largely unknown. Here we
demonstrate for the ﬁrst time that TAF4b is required in the ovary
to initiate and/or complete cyst breakdown, ensure germ cell
survival, and allow for proper primordial follicle development
during this critical window immediately after birth. These data
establish further evidence that TAF4b is in part responsible for an
early regulatory step that ensures ovarian health and fertility.
Fetal germ cell death is known to occur via a number of
mechanisms, including Caspase 2-dependent apoptosis during
cyst breakdown, autophagy, and ovarian shedding (Bergeron et
al., 1998; Morita et al., 2001; Takai et al., 2007; Lobascio et al.,
2007; Tingen et al., 2009). The increased Activated Caspase
3 staining shown here at PND 0 is coincident with the rapid loss
of TAF4b-deﬁcient oocytes (Lobascio et al., 2007; Tingen et al.,
2009). Previous studies by Falender et al. (2005) using this TAF4b-
deﬁcient mouse model utilized TUNEL staining as an indicator of
apoptosis and found no increase in TUNEL-positive cells in TAF4b
(/) ovaries compared to wild-type (Falender et al., 2005). This
is not unexpected, however, as TUNEL staining has been shown to
be an unreliable marker of oocyte apoptosis due to unique germ
cell chromatin conﬁgurations leading to inaccessibility to the
terminal deoxynucleotidyl transferase enzyme (Ghafari et al.,
2007). Our studies using both immunoﬂuorescent detection of
Activated Caspase 3 in vivo, as well as apoptosis inhibition ex vivo,
demonstrate that germ cell loss in TAF4b (/) ovaries is likely
due to classical apoptosis. Germ cell death, and not simply loss of
germ cell marker expression, is further supported by the loss of
germ cell morphology in TAF4b (/) ovaries by PND 1
(Supplementary Figs. 3 and 6). While we observe excessive germ
cell attrition by PND 1 in the TAF4b-deﬁcient ovary, a small but
quantiﬁable number of TAF4b-deﬁcient germ cells persist at or
after this time point (Fig. 1B and C and Supplementary Fig. 3).
These surviving oocytes likely represent a small pool of primordial
follicles that can mature but usually undergo atresia during early
adulthood (Voronina et al., 2007) and are not developmentally
competent (Falender et al., 2005). One possible explanation for the
cell death observed in TAF4b (/) ovaries is that TAF4b may be
involved in an inherent ovarian quality control mechanism that
ensures the survival of the best quality oocytes. Surprisingly, we
have not detected multi-oocyte follicles in the context of the
TAF4b-deﬁcient adult ovary, which are well-documented in other
mouse models of cyst breakdown disruption (Yan et al., 2001; Xu
and Gridley, 2013), reviewed in Silva-Santos and Seneda (2011).
Perhaps the rapid loss of oocytes precludes the ability of the
TAF4b-deﬁcient ovary to form multi-oocyte follicles. Excessive
oocyte apoptosis may result from the aberrant expression of pro-
survival and pro-apoptotic genes in the neonatal TAF4b (/)
ovary. As the expression of these genes is ﬁnely balanced to allow
for the precise level of oocyte survival (Felici et al., 1999; Poljicanin
et al., 2013), ﬁne-tuning of this apoptotic gene expression by
TAF4b may allow for appropriate primordial follicle number.
Furthermore, TAF4b has been shown to regulate expression of
transcriptional regulator c-jun in granulosa cells, and in conjunc-
tion with c-jun regulates expression of ovarian genes (Geles et al.,
2006). TAF4b may perform a similar function in the oocytes along
with transcriptional regulators of oocyte development including
factor in the germline alpha (FIGalpha) (Soyal et al., 2000), Nobox
(Suzumori et al., 2002; Rajkovic et al., 2004), and Lhx8 (Choi et al.,
2008). Future identiﬁcation of the direct transcriptional targets of
TAF4b in the neonatal ovary is critical for understanding the
molecular mechanisms underlying perinatal germ cell survival in
the mouse ovary and may reveal potential therapeutic avenues for
better managing POI in women.
In addition to Z-VAD-FMK treatment, β-estradiol treatment
was shown to inhibit germ cell apoptosis in TAF4b (/) mice.
Previous research has shown β-estradiol treatment to be effective
in preventing oocyte apoptosis in wild-type mice as well (Lei et al.,
2010). It is hypothesized that the observed survival is due to an
estrogen-dependent alteration in pro-survival or oocyte-
development genes (Lei et al., 2010). In contrast to these previous
studies, retention of single, in contrast to cysts, of Tra98-positive
cells in β-estradiol-treated ovaries were observed, though this may
be due to differences in culture lengths or the precise time of β-
estradiol administration. While there are no signiﬁcant differences
in estrogen receptor beta expression in TAF4b (/) mice
(Voronina et al., 2007), aromatase expression was shown to be
down-regulated (Freiman et al. 2001), suggesting that they may
experience decreased estrogen production as neonates. As β-
estradiol treatment helps preserve the oocyte reserve in TAF4b
(/) mice, it is likely that estrogen level, not estrogen response,
is affected in these mice. As estrogen level can be similarly affected
in women suffering from POI (Nelson, 2009), our understanding of
the TAF4b (/) phenotype will lend itself to better under-
standing and treatment of this condition.
The onset of meiotic arrest in prophase I begins around E17.5
and has been proposed to be a steroid hormone-dependent
process (reviewed in Pepling (2012a,b)). Previous research by
Falender et al. (2005) has shown that TAF4b (/) oocytes
experience spindle defects during meiotic maturation, and ferti-
lized TAF4b (/) oocytes do not progress beyond a few
embryonic cell divisions, both of which suggest that meiotic
defects may be responsible for poor developmental competency.
In support of this hypothesis, our previous work in Lovasco et al.
(2010) has shown that a number of critical meiotic genes are
down-regulated in 21-day-old TAF4b (/) mouse ovaries includ-
ing SCM1B and Mad2l1. Finally, Paredes et al. (2005) have shown
that loss of SCP1 in rat oocytes facilitates follicle formation,
indicating that completion of meiosis I may signal individual
oocytes to form primordial follicles. This study emphasizes that
primordial follicle assembly may not only follow meiosis I pro-
gression arrest, but may be dependent upon the proper comple-
tion of these steps. Thus, the potential disruption of steroid
hormone production in the TAF4b-deﬁcient embryonic ovary
may negatively impact meiotic processes known to affect oocyte
survival.
The failure of primordial follicle development in TAF4b (/)
mice may also result from a variety of ovarian deﬁciencies, including
impaired somatic cell invasion into germ cell cysts (Su et al., 2013),
excessive cell–cell adhesion preventing cyst fragmentation (Lechowska
et al., 2011), or a decrease or absence of key cyst breakdown regulators
(Jones and Pepling, 2012). Somatic cell invasion into germ cell cysts is a
critical step towards the process of primordial follicle assembly and
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can be impaired by disruption of cellular pores and channels, altering
the motility and invasion capacity of pre-granulosa cells (Su et al.,
2013). Improper formation of these cellular connections (Lechowska et
al., 2011) may also contribute to the failure of follicle assembly
observed in TAF4b-deﬁcient mice. Finally, follistatin expression, a
key regulator of germ cell survival, primordial follicle formation (Yao
et al., 2004), and developmental competence (Patel et al., 2007) is
signiﬁcantly reduced in juvenile TAF4b (/) mice (Lovasco et al.,
2010). Follistatin is present in a variety of short and long isoforms
which contribute differently to primordial follicle assembly, however
mice lacking either long isoform of follistatin (FST305 or FST315)
experience increased primordial follicle numbers followed by acceler-
ated oocyte death (Kimura et al., 2011). While not identical in
presentation or timing, this phenotype is similar to the neonatal
TAF4b (/) phenotype of increased germ cell density followed by
accelerated oocyte death soon after birth. As TAF4b (/) mice
experience reduced expression of many key folliculogenesis genes, the
initial preservation of oocytes due to reduction in follistatin may be
superseded by deﬁcient cyst breakdown. When oocytes cannot
effectively transition from cysts to follicles, an overriding ovarian
quality control mechanism may sacriﬁce the excess oocytes earlier
than is observed in mice lacking full-length follistatin. As TAF4b is
expressed in both somatic and germ cells in the ovary, it is possible
that TAF4b may play multiple roles leading to proper primordial
follicle formation. Further studies elucidating these functions will shed
light on the precise transcriptional regulatory steps required for proper
mammalian ovarian follicle development and fertility, as well as the
speciﬁc cell death pathways involved in inappropriate oocyte loss and
infertility.
Materials and methods
Mouse models
Wild-type (TAF4b (þ/þ)) and TAF4b null (/) or hetero-
zygous (þ/) mice were generated by mating heterozygous
TAF4b (þ/) male and female mice as described previously
(Freiman et al., 2001). Offspring were genotyped by PCR analysis
of tail-snip genomic DNA amplifying the region targeted by
homologous recombination. All animal protocols were reviewed
and approved by Brown University Institutional Animal Care and
Use Committee and were performed in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
Neonatal ovary cultures
Timed matings of 8-week-old mice were set up in the evening;
presence of copulation plugs the following morning indicated
successful mating and was considered embryonic day 0.5 (E0.5).
Pregnant females were euthanized by CO2 inhalation at the
appropriate time points and TAF4b (þ/þ), (þ/) and (/)
ovaries were harvested from E18.5 embryos for neonatal organ
culture until PND 2 as described (Chen et al., 2007) in ovary
culture media [DMEM/Ham F-12 supplemented with L-glutamine
(Life Technologies), 1 mg/ml bovine serum albumin (Sigma),
0.5 mg/ml Albumax (Life Technologies), 50 mg/ml ascorbic acid
(Sigma), 27.5 mg/ml transferrin (Sigma) and 0.1 mg/ml 10,000 U/ml
penicillin/5 mg/ml streptomycin (Life Technologies)].
One ovary per mouse was cultured in “control media”, while
the other was cultured in “treated media”. Treated media
contained 50 mM Z-VAD-FMK (R&D Systems) in DMSO or 10 nm
β-estradiol (Sigma-Aldrich) in 100% ethanol, while control media
contained an appropriate amount of the respective solvent in the
ovary culture media. Media was changed every other day and on
PND 2, ovaries were embedded in Optimal Cutting Temperature
Compound (Tissue-Tek) for sectioning.
Quantitative immunoﬂuorescence
Ovaries were removed, cleaned of excess fat, and ﬁxed in 4%
formaldehyde solution overnight before embedding in Optimal
Cutting Temperature Compound. Ovaries were serially sectioned
at 8 uM on a Leica Cryostat onto glass slides and washed in
1 Phosphate-Buffered Saline containing 0.01% Triton-X (CalBio-
chem). The entire tissue was sectioned and the median, adjacent
two sections chosen for staining and quantiﬁcation. Tissue sec-
tions were then incubated in blocking buffer (3% Goat Serum
(Sigma), 1% Bovine Serum Albumin (Sigma), and 0.5% Tween-20
(Fisher Scientiﬁc) in 1 PBS) and stained by incubation with
primary antibodies against Tra98 (B-Bridge) and Mouse Vasa
Homolog (Abcam) for germ cell counting, or Tra98 and Activated
Caspase 3 (Cell Signaling) for apoptosis analysis. A secondary
antibody‐only control was included to compare background stain-
ing. Sections were further stained with DAPI to visualize nuclei
and analyzed on an Epiﬂuorescent Zeiss Axioplan microscope.
Germ cell densities were determined by counting total Tra98-
positive cells and dividing the total number by the DAPI area to
obtain cells/mm2, or density of germ cells in the ovary. For each
treatment group, at least two ovary tissues sections each from at
least four mice were quantiﬁed. Results were averaged and
signiﬁcance determined by two-tailed T-test. Error bars represent
standard error of the mean. Percentages of Activated Caspase 3-
positive oocytes were determined by counting cells positive for
both Tra98 and Activated Caspase 3 and dividing by the total
number of Tra98-positive cells per section. Results were averaged
and signiﬁcance determined by two-tailed T-test. Error bars
represent standard error of the mean.
Ovarian histology
Ovaries were removed at E18.5, PND 0 and PND 1, cleaned of
excess fat and bursal sac, and ﬁxed in 1:10 formalin solution
overnight. Standard parafﬁn embedding, microtome sectioning,
and hematoxylin and eosin staining were performed. Images were
taken using the Scanscope CS (Aperio).
Ovarian GCNA immunohistochemistry
Ovaries were removed at E18.5, PND 0 and PND 1, cleaned of
excess fat and bursal sac, and ﬁxed in 1:10 formalin solution
overnight. Standard parafﬁn embedding and microtome sectioning
were performed. Sections were deparafﬁnized and antigen
unmasking was performed with 1:10 Antigen Unmasking Buffer
(Vector Laboratories). Sections were cooled and permeabilized in
0.1% Triton for 10 min prior to Avidin–biotin blocking with an
Avidin–Biotin Blocking Kit (Vector Laboratories) according to
manufacturer's directions. Sections were blocked in PBS with 1%
Bovine Serum Albumin and 6% ready-to-use goat serum before
incubating overnight at 4 1C with undiluted rat anti-GCNA anti-
body (gift from laboratory of Dr. David Page). The following day,
sections were washed and incubated with biotinylated anti-rat IgG
antibodies (Vector Laboratories), for 1 h at room temperature.
After PBS wash, sections were incubated in a ready-to-use ABC
Vectastain reagent (Vector Laboratories) for 45 min and washed.
Sections were then developed in Vector NovaRED substrate
(Vector Laboratories). Nuclei were counter-stained using Methyl
Green (Vector Laboratories). Slides were cleaned with isopropyl
alcohol and successive Citrisolv Hybrid (Fisher Scientiﬁc) washes
and mounted with Cytoseal 60 mounting media (Richard-Allan
K.J. Grive et al. / Developmental Biology 392 (2014) 42–51 49
Scientiﬁc). Stained sections were imaged at 20 magniﬁcation
with a ScanScope CS imaging system (Aperio).
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